Alzheimer Disease Therapeutic Market Pipeline Overview, Drugs & Key Players Profiles H2 2014
The report "Alzheimer’s Disease – Pipeline Review, H2 2014" provides comprehensive information on the therapeutic development for Alzheimer’s Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Alzheimer’s Disease and special features on late-stage and discontinued projects. Alzheimer's infection (AD), otherwise called Alzheimer sickness,...
View full press release